癌症药物再利用的挑战和机遇,由合成杀伤性告知
Michael Vermeulen1, Andrew W Craig2,3, Tomas Babak4,5
1Department of Biology, Queen's University, Kingston, ON, Canada. 0mcv@queensu.ca.
NPJ systems biology and applications
|December 13, 2025
概括
合成致死性针对来自瘤抑制基因突变的癌症脆弱性. 研究人员确定了药物重定向的机会,但发现遗传和药物效应往往不同,需要新的评估方法.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 三分之二的癌症源于瘤抑制基因突变,但有针对性的治疗方法很少.
- 合成致死性为利用癌症特异性脆弱性提供了一个有希望的策略.
- 确定可靠的合成致命相互作用对于开发新的癌症治疗方法至关重要.
研究的目的:
- 为了确定针对癌症治疗的临床相关的合成致命相互作用.
- 发现基于合成致命性的潜在药物重新利用机会.
- 评估基因干扰与癌症中药物效应之间的一致性.
主要方法:
- 从癌症依赖地图分析了全基因组的CRISPR/Cas9淘汰 (KO) 活力屏幕.
- 在患者瘤中使用相互排他性的相互作用的评估临床相关性.
- 综合药物敏感性数据以识别模仿遗传KO效应的抑制剂.
主要成果:
- 在涉及癌症驱动基因的相互作用中发现了显著的相互排他性丰富.
- 确定了潜在的药物重定位:用于ARID1A突变膀癌的BRD2抑制剂和用于SIN3A突变细胞的NAMPT抑制剂.
- 发现药理抑制剂经常无法复制遗传KO效应.
结论:
- 合成致死性是一种可行的策略,用于识别癌症依赖性和治疗点.
- 基于基因选的药物重定向显示出希望,但需要仔细验证.
- 遗传和药物干扰之间存在根本的差异,需要新的方法来评估与特定突变相关的药物疗效.
更多相关视频
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.5K
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
11.1K
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:26Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:18Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K